Halda Therapeutics
New Haven, US · Founded 2018 · Delaware LLC · 39,024 employees on LinkedIn · 7 known investors
Founders & leadership
Board
TS
LR
Investors · 7
Reported raises · per SEC filings
Form D private placements$197.9M disclosed across 4 rounds · 2019–2024
▶$126.5MraisedAug 2024 · 20 investors · Other Health CareRule 506(b)
▶$126.5MraisedAug 2024 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Liam RatcliffeDirector
- Nandita ShangariDirector
- Tim ShannonExecutive Officer, Director
- Joe CabralDirector
- Rebecca FreyDirector
- Rebecca LuseDirector
- Arjun GoyalDirector
- Scott PhillipsExecutive Officer
- Offering amount
- $126.5M
- Amount sold
- $126.5M
- First sale
- Jul 2024
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$24.2MraisedMay 2024 · 9 investors · Other Health CareRule 506(b)
▶$24.2MraisedMay 2024 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Liam RatcliffeDirector
- Rebecca FreyDirector
- Tim ShannonExecutive Officer, Director
- Scott PhillipsExecutive Officer
- Offering amount
- $36M
- Amount sold
- $24.2M
- First sale
- May 2024
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$41MraisedDec 2021 · 11 investors · BiotechnologyRule 506(b)
▶$41MraisedDec 2021 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott PhillipsExecutive Officer
- Tim ShannonExecutive Officer, Director
- Liam RatcliffeDirector
- Leyi WangDirector
- Rebecca FreyDirector
- Offering amount
- $51M
- Amount sold
- $41M
- First sale
- Dec 2021
- Incorporated
- Limited Liability Company, Delaware, 2018
- Federal exemptions
- 06b
▶$6.3MraisedMar 2019 · 12 investors · Other Health CareRule 506(b)
▶$6.3MraisedMar 2019 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Scott PhillipsExecutive Officer
- Tim ShannonExecutive Officer, Director
- Wei ZhaoDirector
- Offering amount
- $25.1M
- Amount sold
- $6.3M
- First sale
- Feb 2019
- Incorporated
- Limited Liability Company, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Halda Therapeutics went on to found or lead other companies.
Competitors · 3
by search overlapBioworld14 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Atalanta10 shared keywordsAtalanta is developing treatment options for intractable central nervous system diseases using RNA interference technology. The company was founded by leading experts in RNAi research.
Johnson & Johnson9 shared keywordsJohnson & Johnson develops prescription medicines and medical technology across areas including oncology, immunology, neuroscience, cardiopulmonary, cardiovascular, orthopaedics, surgery, and vision. Its two main businesses, Innovative Medicine and MedTech, focus on treating complex diseases through science-based drugs and less invasive, personalized medical devices.
Companies competing with Halda Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- Who are Halda Therapeutics's investors?
- Halda Therapeutics's investors include Access Biotechnology, Canaan Partners, Connecticut Innovations, Frazier Life Sciences, RA Capital, Taiho Ventures, LLC, Vida Ventures.
- How much funding has Halda Therapeutics raised?
- Halda Therapeutics has disclosed $197.9M raised across 4 rounds.
- Where is Halda Therapeutics headquartered?
- Halda Therapeutics is headquartered in New Haven, US.